Gene Therapy for Duchenne Muscular Dystrophy (DMD)
The US FDA has now preliminarily approved a drug called Elevidys to be used as gene therapy for Duchenne Muscular Dystrophy (DMD) in children. The drugmaker Sarepta Therapeutics Inc. said it would charge $3.2 million for the one-time treatment.
June 26, 2023